The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Open accessPublished version of a preprint
Abstract
Recent population studies provide clues that the use of metformin may be associated with reduced incidence and improved prognosis of certain cancers. This drug is widely used in the treatment of type 2 diabetes, where it is often referred to as an "insulin sensitizer" because it not only lowers blood glucose but also reduces the hyperinsulinemia associated with insulin resistance. As insulin and insulin-like growth factors stimulate proliferation of many normal and transformed cell types, agents that facilitate signaling through these receptors would be expected to enhance proliferation. We show here that metformin acts as a growth inhibitor rather than an insulin sensitizer for epithelial cells. Breast cancer cells can be protected against metformin-induced growth inhibition by small interfering RNA against AMP kinase. This shows that AMP kinase pathway activation by metformin, recently shown to be necessary for metformin inhibition of gluconeogenesis in hepatocytes, is also involved in metformin-induced growth inhibition of epithelial cells. The growth inhibition was associated with decreased mammalian target of rapamycin and S6 kinase activation and a general decrease in mRNA translation. These results provide evidence for a mechanism that may contribute to the antineoplastic effects of metformin suggested by recent population studies and justify further work to explore potential roles for activators of AMP kinase in cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some of these mechanisms may be through inhibition of cell growth [148], IGF-1 signaling [149], inhibition of the mTOR pathway [150], reduction of human epidermal growth factor receptor type 2 (HER-2) expression (a major driver of proliferation in breast cancer) [151], inhibition of angiogenesis and inflammation [152], induction of apoptosis and protein 53 (p53) activation [153], cell cycle arrest”
From Metformin: An Old But Still the Best Treatment for Type 2 Diabetes (2013) · cites this paper as [150]
In the citing paper
“and interference with glucose(266), protein(267, 268), and lipid(269) metabolism of the neoplastic cells.”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [268]
In the citing paper
“In laboratory studies, metformin has been shown to inhibit cell proliferation, reduce colony formation, and cause partial cell cycle arrest in cancer cell lines (81–83).”
From Diabetes and Cancer (2010) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Shaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
A serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I. P. M., Avizienyte, E., Roth, S., Loukola, A., Bignell, G. R., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,680
Insulin-like growth factors and neoplasia
Pollak, M., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1387 · Cited by 1,477
Self-citationVery high risk of cancer in familial Peutz–Jeghers syndrome
Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435
The LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N. M., Manning, B. D., Lopez, L. V., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,107
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 978
Cited by
Sorted by citations
Items 801–900 of 1,000
Liou, W., Chen, L.-J., Niu, H., Yang, T., Cheng, J., & Lin, K. (2014) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2014.11.001 · Cited by 10
Metformin for the Prevention of Bladder Cancer Recurrence: Is it Effective?
Heidari, F., Zade, S. A., Hosseini, S. H. M., & Ghadian, A. (2016) · Nephro-Urology Monthly · doi:10.5812/numonthly.30261 · Cited by 10
Metformin for lung cancer prevention and improved survival: a novel approach
Roos, J. F., Qudsi, M., Samara, A., Rahim, M. M., Al-Bayedh, S. A., & Ahmed, H. (2018) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000442 · Cited by 11
Viglianisi, G., Polizzi, A., Grippaudo, C., Cocuzza, S. G., Leonardi, R. M., & Isola, G. (2024) · Bioengineering · doi:10.3390/bioengineering11010065 · Cited by 9
Mei, J., Tian, H., Huang, H.-S., Wu, N., Liou, Y., Chu, T., Wang, J., & Zhang, W. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2109362 · Cited by 9
Metformin: A possible drug for treatment of endometrial cancer
Tsuji, K., Kisu, I., Banno, K., Yanokura, M., Ueki, A., Masuda, K., Kobayashi, Y., Yamagami, W., Nomura, H., Susumu, N., et al. (2012) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2012.21001 · Cited by 9
AMPK signaling: A targetable tumor suppressor pathway?
Schneider, A., & Gartenhaus, R. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13921 · Cited by 9
Metformin and Hepatic Carcinogenesis
Pollak, M., & Gonzalez-Angulo, A. M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0080 · Cited by 9
Self-citationBarakat, H. E., Hussein, R. R. S., Elberry, A. A., Zaki, M. A., & Ramadan, M. E. (2022) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2022.2051482 · Cited by 10
Adachi, S., Yasuda, I., Kawaguchi, J., Yamauchi, T., Nakashima, M., Itani, M., Nakamura, M., Yoshioka, T., Moriwaki, H., & Kozawa, O. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.020 · Cited by 9
Obesity, Diabetes and Cancer: A Mechanistic Perspective
Cifarelli, V., & Hursting, S. (2015) · International Journal of Diabetology & Vascular Disease Research · doi:10.19070/2328-353x-si04001 · Cited by 9
Cao, Y., Zhao, Z., Fang, J., Lu, Y., Huang, Z., Wu, G., Gao, Q., Li, R., Xu, L., & Xu, X. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202500646 · Cited by 8
AMPK Deficiency Increases DNA Methylation and Aggravates Colorectal Tumorigenesis in AOM/DSS Mice
Sun, Q., Tian, Q., Iniguez, A. B., Sun, X., Zhang, H., de Avila, J. M., Du, ., & Zhu, M. J. (2024) · Genes · doi:10.3390/genes15070835 · Cited by 8
Hamedi, B., Khalili, A., Roozmeh, S., Namazi, G., & Saraf, Z. (2018) · International Journal of Cancer Management · doi:10.5812/ijcm.11621 · Cited by 8
Sundelin, E. I. O., Al-Suliman, N. N., Vahl, P., Vendelbo, M. H., Munk, O. L., Jakobsen, S., Pedersen, S. B., Frøkiær, J., Gormsen, L. C., & Jessen, N. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05621-6 · Cited by 8
Huang, C., Lin, Y., Hung, C.-H., Chen, H., Lin, J., Wang, C., & Kao, S. (2021) · Pharmaceuticals · doi:10.3390/ph14090860 · Cited by 8
RetractedWatson, J. D. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0220 · Cited by 8
Duchnowska, R., for the Central and East European Oncology Group (CEEOG), Wysocki, P. J., Korski, K., Czartoryska-Arłukowicz, B., Niwińska, A., Orlikowska, M., Radecka, B. S., Studziński, M., Demlová, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6375 · Cited by 8
Hamilton, N. M., Márquez‐Garbán, D. C., Mah, V. H., Elshimali, Y., Elashoff, D. A., Garon, E. B., Vadgama, J. V., & Pietras, R. J. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.100 · Cited by 8
Energy Metabolism, Cancer Risk, and Cancer Prevention
Pollak, M. (2008) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-69297-3_5 · Cited by 8
Self-citationMetformin - A Panacea Pharmaceutical Agent through convergence revolution initiative
Prabhakaran, S., Thirumal, D., Gimbun, J., Ranganathan, B., & Palms Connect Sdn Bhd, S. A. 4. (2017) · Journal of Natural Remedies · doi:10.18311/jnr/2017/17938 · Cited by 8
Kwon, Y., Chun, S., Nan, H., Nam, K., Lee, C., & Kim, S. Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.9827 · Cited by 7
Markowicz-Piasecka, M., Komeil, I. A., Huttunen, J., Sikora, J., & Huttunen, K. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072389 · Cited by 8
Godara, A., Siddiqui, N. S., Hachem, H., Tsichlis, P. N., Martell, R. E., & Saif, M. W. (2020) · Journal of Cellular Signaling · doi:10.33696/signaling.1.008 · Cited by 8
Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma
Chiyo, T., Kato, K., Iwama, H., Fujihara, S., Fujita, K., Tadokoro, T., Oura, K., Samukawa, E., Yamana, Y., Kobayashi, N., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3971 · Cited by 8
What are the Optimal Systemic Treatment Options for Rhabdomyosarcoma?
Miwa, S., Hayashi, K., Taniguchi, Y., Asano, Y., & Demura, S. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01206-3 · Cited by 7
Dissanayake, I. H., Alsherbiny, M. A., Stack, C. M., Chang, D., Li, C. G., Kaur, K., & Bhuyan, D. J. (2024) · Food & Function · doi:10.1039/d4fo01155d · Cited by 8
Xu, J., Zhu, Q.-L., Bi, Y.-M., & Peng, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-12453-w · Cited by 10
Breast Tissue Biology Expands the Possibilities for Prevention of Age-Related Breast Cancers
Fresques, T., Zirbes, A., Shalabi, S., Samson, S., Preto, S., Stampfer, M. R., & LaBarge, M. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00174 · Cited by 7
A-activated protein kinase is required for cell survival and growth in hela-s3 cellsin vivo
Song, X., Huang, D., Liu, Y., Pan, X., Zhang, J., & Liang, B. (2014) · IUBMB Life · doi:10.1002/iub.1279 · Cited by 7
Use of metformin is associated with lower incidence of cancer in patients with type 2 diabetes
Muszyńska-Ogłaza, A., Zarzycka-Lindner, G., Olejniczak, H., Polaszewska-Muszyńska, M., & Junik, R. (2015) · Endokrynologia Polska · doi:10.5603/ep.a2017.0054 · Cited by 7
Kabir, E. R., Siam, M. K. S., Kabir, S. M., Khan, A. H., & Rajib, S. A. (2017) · International Conference Computational Systems-Biology and Bioinformatics · doi:10.1145/3156346.3156359 · Cited by 7
Tully, E., Bharti, S. K., Woo, J., Bhujwalla, Z. M., & Gabrielson, E. W. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1982599 · Cited by 7
Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells
Adam, L., Stanifer, M. L., Springer, F., Mathony, J., Brune, M., Ponzio, C. D., Eils, R., Boulant, S., Niopek, D., & Kallenberger, S. M. (2023) · Science Signaling · doi:10.1126/scisignal.abl8266 · Cited by 7
Investigating the effect of metformin on chemobrain: Reports from cells to bedside
Leddy, E., Attachaipanich, T., Chattipakorn, N., & Chattipakorn, S. C. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115129 · Cited by 6
Sakamoto, K., Okabayashi, K., Matsui, S., Seishima, R., Shigeta, K., & Kitagawa, Y. (2022) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-022-05354-5 · Cited by 6
Electroporation enhances cell death in 3D scaffold-based MDA-MB-231 cells treated with metformin
Sahu, P., Camarillo, I. G., Dettin, M., Zamuner, A., Conconi, M. T., Barozzi, M., Giri, P., Sundararajan, R., & Sieni, E. (2024) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2024.108734 · Cited by 6
Making sense of associations between type 2 diabetes, metformin, and breast cancer risk
Park, Y., & Sandler, D. P. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01372-3 · Cited by 6
van Hattum, J. W., de Ruiter, B. M., Oddens, J. R., de Reijke, T. M., Wilmink, J. W., & Molenaar, R. J. (2022) · Bladder Cancer · doi:10.3233/blc-211653 · Cited by 6
Gong, X., Wu, J., Wen, J., Ding, X., Xu, N., Sun, M., Yu, G., Liu, S., Zhang, B., & Liu, H. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.2c01027 · Cited by 6
Advanced treatment strategies in breast cancer: A comprehensive mechanistic review
Mumtaz, S., Ali, S., Mumtaz, S., Pervaiz, A., Tahir, H. M., Farooq, M. A., & Mughal, T. A. (2023) · Science Progress · doi:10.1177/00368504231175331 · Cited by 6
Wang, L., Yu, M., Liu, C.-L., Wu, Z., Wu, M., Sun, Y., & Li, Y. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138084 · Cited by 6
Analyses of Biguanides and Related Compounds in Biological and Environmental Samples by HPLC
Ali, I., Hussain, I., Sanagi, M. M., Ibrahim, W. A. W., & Aboul-Enein, H. Y. (2014) · Journal of Liquid Chromatography & Related Technologies · doi:10.1080/10826076.2014.940803 · Cited by 6
Prevention of Lung Cancer: Future Perspective with Natural Compounds
Brandes, J. C., Amin, R., Khuri, F. R., & Shin, D. M. (2010) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2010.69.1.1 · Cited by 6
Fröhlich, E., & Wahl, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01491.x · Cited by 6
How treatments with endocrine and metabolic drugs influence pituitary cell function
Tulipano, G. (2020) · Endocrine Connections · doi:10.1530/ec-19-0482 · Cited by 6
Metformin – from Devil to Angel
Schernthaner, G., & Schernthaner, G.-H. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6_9 · Cited by 6
The Future of Systemic Therapies for Localised Prostate Cancer
Eigl, B. J., Gleave, M. E., & Chi, K. N. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.04.002 · Cited by 6
Bradford, S. A. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000197 · Cited by 6
Pollak, M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0134 · Cited by 6
Self-citationDiabetes and Nonalcoholic Fatty Liver Disease
Kantartzis, K., Gastaldelli, A., Magkos, F., & Lavoie, J.-M. (2011) · Experimental Diabetes Research · doi:10.1155/2012/404632 · Cited by 5
Knowledge mapping of metformin use on cancers: a bibliometric analysis (2013–2023)
Pan, C., Wei, Y., Dai, J., Yang, L., Ding, Z., & Wang, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388253 · Cited by 5
Szemerédi, N., Schelz, Z., Horvath, D. A., Rácz, B., Szatmári, A. G., Muddather, H. F., Bózsity, N., Zupkó, I., & Spengler, G. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070877 · Cited by 7
Gennari, A., Sormani, M. P., Puntoni, M., Martini, V., Amaro, A. A., Bruzzi, P., & Pfeffer, U. (2020) · Breast Care · doi:10.1159/000509207 · Cited by 5
Nurzhan, S., Bekezhankyzy, Z., Ding, H., Berdigaliyev, N., Sergazy, S. D., Gulyayev, A., Shulgau, Z., Triggle, C. R., & Aljofan, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092186 · Cited by 5
Novel approach to target cancer stem cells for therapy
Ajumeera, R. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.11.009 · Cited by 5
Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers
Kumar, N. B. (2012) · Hereditary Genetics · doi:10.4172/2161-1041.1000104 · Cited by 5
Kim, Y.-S., Park, J.-S., Kim, M., Hwang, B. Y., Lee, C., & Song, S. (2017) · Natural Product Sciences · doi:10.20307/nps.2017.23.1.35 · Cited by 5
Babak, M. V., Chong, K. R., Rapta, P., Ζαννίκου, Μ., Tang, H. M., Reichert, L., Chang, M. R., Kushnarev, V. A., Heffeter, P., Meier, S. M., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202102266 · Cited by 5
The Antiproliferative Potential and Mechanism of Action of Metformin in MCF-7 Cells
Bekezhankyzy, Z., Nurzhan, S., Berdigaliyev, N., Sergazy, S. D., Maulenkul, T., & Aljofan, M. (2023) · Future Science OA · doi:10.2144/fsoa-2022-0080 · Cited by 5
Viollet, B., & Foretz, M. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70183-3 · Cited by 5
Park, C., Han, M., Park, S., Hong, S. H., Kim, G., Moon, S., Kim, W., & Choi, Y. H. (2016) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2016.11.003 · Cited by 5
Behrouzi, B., Zokaasadi, M., Mohagheghi, M. A., Emami, A., & Sadighi, S. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.2.611 · Cited by 5
The role of insulin-like growth factors (IGF) in cell division processes and in malignancy
Vasas, P., Winslet, M. C., & Yang, S. Y. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28733 · Cited by 5
Glucose intolerance and the risk of pancreatic cancer
Ito, M., Makino, N., & Ueno, Y. (2013) · Translational gastrointestinal cancer · Cited by 5
Brown, K. A., Andreopoulou, E., & Andreopoulou, P. (2020) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2020.16.1.17 · Cited by 5
Lv, G., Zong, Q., Wang, L., Lv, H., Wu, Z., Liu, C., Wang, S., Cao, D., Wang, Y., & Yang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217978 · Cited by 4
The main directions and prospects in polycystic ovary syndrome treatment
Наримановна, У. А., Egorova, E. A., Yelisheva, E. A., Beitullaev, А. М., & Koryanova, K. N. (2021) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20210602 · Cited by 4
Zhuang, Y., Haugrud, A. B., Schaefer, M. A., Messerli, S. M., & Miskimins, W. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1225220 · Cited by 4
A doxycycline-loaded microfiber of poly-metformin/PCL for eradicating melanoma stem cells
Zarei, B., Akrami, M., Rezaei, N., Mahdavi, M. R., Kamankesh, M., Haririan, I., Asadi, M., & Nigjeh, M. N. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124358 · Cited by 4
mTOR and Regulation of Translation
Tsukumo, Y., Laplante, M., Parsyan, A. E., Ruggero, D., & Fonseca, B. D. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_15 · Cited by 5
Lee, J. H., & Kim, T. I. (2013) · Current Colorectal Cancer Reports · doi:10.1007/s11888-013-0198-x · Cited by 5
Merrick, G. S., Bennett, A., Couture, T., Butler, W. M., Galbreath, R. W., & Adamovich, E. (2015) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000174 · Cited by 4
Insulin and Insulin-Like Growth Factor-1 Associated Cancers
Dey, S. K., & Senapati, S. (2021) · Springer eBooks · doi:10.1007/978-981-16-1846-8_3 · Cited by 4
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer
Waissengrin, B., Zahavi, T., Salmon‐Divon, M., Goldberg, A., Wolf, I., Rubinek, T., Winkler, T., Farkash, O., Grinshpun, A., Zubkov, A., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100648 · Cited by 4
Chen, J., Jin, H., Zhou, H., & Liu, K. (2023) · Medicina · doi:10.3390/medicina59020298 · Cited by 4
Insulin, Insulin Resistance, and Cancer Associations
Lipscombe, L. L. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_5 · Cited by 4
Mecanismos antitumorales de la metformina: señalización, metabolismo, inmunidad y más allá.
Duque, J. E., López, C., Cruz, N., & Samudio, I. J. (2010) · Universitas Scientiarum · doi:10.11144/javeriana.sc15-2.amom · Cited by 6
What Benefits Could Caloric Restriction Bring to Cancer Patients?
Dan, T., Wright, C. M., & Simone, N. L. (2014) · Future Oncology · doi:10.2217/fon.14.241 · Cited by 5
Impact of Concurrent Coincident Use of Metformin During Lung Stereotactic Body Radiation Therapy
Stang, K., Alite, F., Adams, W., Altoos, B., Small, C., Melian, E., Emami, B., & Harkenrider, M. M. (2021) · Cureus · doi:10.7759/cureus.14157 · Cited by 4
Potential Mechanisms Linking Insulin to Cancer
Babichev, Y., Khalid, S., & Fantus, I. G. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_7 · Cited by 4
Self-citationZeljković, V., Bogavac, M. A., Dekić, M., Minić, S., Mahmutović, E., Kunkin, V., Marković, Z., & Karaman, M. (2026) · Molecules · doi:10.3390/molecules31111877 · Cited by 4
Structural basis of polypharmacological effects of metformin
Han, W., & Xie, L. (2012) · IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) · doi:10.1109/bibmw.2012.6470337 · Cited by 3
Ajumeera, R., Ganapathi, T., Padya, B. S., Tirumala, L., & Challa, S. (2022) · Nutrition and Health · doi:10.1177/02601060221137624 · Cited by 3
Li, L., Huang, J., Huang, T., Yao, J., Zhang, Y., Chen, M., Shentu, H., & Lou, H. (2023) · International Journal of Endocrinology · doi:10.1155/2023/5892731 · Cited by 3
Metformin targets the GTPase Rac1 to inhibit prostate cancer cell migration
Dirat, B., Ader, I., Golzio, M., Mettouchi, A., Laurent, K., Larbret, F., Malavaud, B. A., Cormont, M., Lemichez, E., Tanti, J., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-s1-o24 · Cited by 3
Sekar, A. P., Nurmala, S., Matsuura, E., Tan, X. W., Rahmasari, R., & Sauriasari, R. (2024) · Breast Cancer Basic and Clinical Research · doi:10.1177/11782234241240173 · Cited by 3
Maruzen, S., Munesue, S., Okazaki, M., Takada, S., Nakanuma, S., Makino, I., Gong, L., Kohno, S., Takahashi, C., Tajima, H., et al. (2024) · Onco · doi:10.3390/onco4020007 · Cited by 3
Wang, Y., Sun, Y., Hu, J., & Ma, H. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s495449 · Cited by 3
Amato, R. J., Xiong, Y., Peng, H., & Mohlere, V. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000112 · Cited by 3
Kiliccioglu, I., Konaç, E., Albayrak, G., Dönmez, Ç., & Bilen, C. Y. (2015) · Gazi Medical Journal · doi:10.12996/gmj.2015.65 · Cited by 3
Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver
Sekiba, K., Otsuka, M., & Koike, K. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1723033 · Cited by 3
Chou, C.-C., Salunke, S. B., Kulp, S. K., & Chen, C. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24704 · Cited by 3
Berstein, L. M., Vasilyev, D. A., Iyevleva, A. G., Boyarkina, M. P., Евгеньевна, П. Т., Khadzhimba, A. S., & Имянитов, Е. Н. (2015) · Future Oncology · doi:10.2217/fon.14.317 · Cited by 3
Doses, mechanisms and the dandelion and hormetic phenomena
Martı́n-Castillo, B., Vázquez‐Martín, A., Oliveras‐Ferraros, C., & Menéndez, J. A. (2010) · Cited by 3
Nozhat, Z., Zarkesh, M., Baldini, E., Mohammadi‐Yeganeh, S., Azizi, F., & Hedayati, M. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210118093532 · Cited by 3
Mechanisms Linking Obesity to Cancer Risk
Imayama, I., Mason, C. E., & Duggan, C. R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7551-5_6 · Cited by 3
The Epidemiologic Relationship between Diabetes and Cancer
nker, K. S. Z. A. (2008) · Frontiers in diabetes · doi:10.1159/000152026 · Cited by 3
Aurilio, G., Serrano, D., Lazzeroni, M., Guerrieri‐Gonzaga, A., Johansson, H. A., Gandini, S., Briata, I. M., D’Amico, M., Spinaci, S., Veronesi, P., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00745-8 · Cited by 3
Metadata
- Authors
- Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M.
- Affiliations
- 1Oncology and Departments of
- McGill University (CA)
- Mount Sinai Hospital (CA)
- Venue
- Cancer Research
- Published
- 2006-11-01
- Volume
- 66
- Issue
- 21
- Pages
- 10269-10273
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2078190084
- Cited by
- 1,048
- References
- 20
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 24 · 2023: 29 · 2022: 28 · 2021: 54 · 2020: 47 · 2019: 62 · 2018: 55 · 2017: 70 · 2016: 70 · 2015: 80 · 2014: 93 · 2013: 86 · 2012: 85
- FWCI
- 12.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Canadian Breast Cancer Research Alliance
- Terry Fox Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- metformin, AMP kinase, breast cancer, cell growth inhibition, antineoplastic effects, mTOR, S6 kinase, mRNA translation, insulin resistance, insulin-like growth factor, epithelial cells, cancer prevention
- MeSH terms
- Adenylate Kinase, Antineoplastic Agents, Breast Neoplasms, Female, Humans, Insulin, Metformin, Protein Biosynthesis, Gene Expression Regulation, Enzymologic, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
